Featured
April 28, 2026
ASAP and MJFF announced $261 million in new grant funding for the Collaborative Research Network (CRN) to map the biological blueprint of Parkinson’s disease and build a standardized toolkit of global research resources that are needed to turn discoveries into treatments.
Read More
Parkinson’s News Today reports that ASAP and The Michael J. Fox Foundation are investing $261 million to expand the Collaborative Research Network (CRN) to better understand what drives Parkinson’s disease and to accelerate the development of more personalized therapies.
View Story
This blog discusses how ASAP's latest investment aims to accelerate medical breakthroughs by creating a global, open-science toolkit of standardized resources and tools to overcome existing research barriers to overcome existing research barriers.
Read More
Parkinson’s News Today reports that the ASAP has awarded a $9 million grant to scientists from Cedars-Sinai, to investigate how exposure to specific pesticides and air pollutants interacts with genetic vulnerabilities to trigger the development of the disease.
View Story
The Guardian reports on a breakthrough study by CRN Team Schapira, which identified a distinct gut microbial "signature" that can signal Parkinson's risk years before physical symptoms appear.
View Story
ASAP and MJFF announced $261 million in new grant funding for the Collaborative Research Network (CRN) to map the biological blueprint of Parkinson’s disease and build a standardized toolkit of global research resources that are needed to turn discoveries into treatments.
Read More
ASAP is proud to showcase the inaugural cohort of Discovery Fellows. Learn more about the funded projects!
Read More
In this edition of the ASAP Research Round-Up, ASAP presents Q1 2026 highlights from across its portfolio, showcasing efforts to advance Parkinson’s discovery, facilitate the rapid global exchange of ideas, broaden open-science accessibility, and support the next generation of Parkinson’s researchers.
Read More
On genomics podcast Mendelspod, Andy Singleton, co-lead of the Global Parkinson's Genetics Program (GP2), and Nacho Mata, Cleveland Clinic geneticist and LARGE-PD founder, discuss how GP2 is accelerating discovery and expanding global representation in Parkinson’s research.
View Story
Reports that the College of Medicine, University of Lagos (CMUL) commissioned the GP2–CMUL Molecular Laboratory to strengthen Parkinson’s disease research, genomics capacity, and training opportunities across Africa in collaboration with Aligning Science Across Parkinson’s (ASAP) and the Global Parkinson’s Genetics Program (GP2).
Read More
